Literature DB >> 31840508

Mercury-Free Automated Synthesis of Guanidinium Backbone Oligonucleotides.

Kacper Skakuj1, Katherine E Bujold1, Chad A Mirkin1.   

Abstract

A new method for synthesizing deoxynucleic guanidine (DNG) oligonucleotides that uses iodine as a mild and inexpensive coupling reagent is reported. This method eliminates the need for the toxic mercury salts and pungent thiophenol historically used in methods aimed at preparing DNG oligonucleotides. This coupling strategy was readily translated to a standard MerMade 12 oligonucleotide synthesizer with coupling yields of 95% and has enabled the synthesis of a 20-mer DNG oligonucleotide, the longest DNG strand to date, in addition to mixed DNA-DNG sequences with 3-9 DNG inserts. Importantly, DNG oligonucleotides exhibit robust unaided cellular uptake as compared to unmodified oligonucleotides without apparent cellular toxicity. Taken together, these findings should greatly increase the accessibility of cationic backbone modifications and assist in the development of oligonucleotide-based drugs.

Entities:  

Year:  2019        PMID: 31840508      PMCID: PMC7027944          DOI: 10.1021/jacs.9b09937

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  28 in total

Review 1.  The Medicinal Chemistry of Therapeutic Oligonucleotides.

Authors:  W Brad Wan; Punit P Seth
Journal:  J Med Chem       Date:  2016-07-29       Impact factor: 7.446

Review 2.  The chemical evolution of oligonucleotide therapies of clinical utility.

Authors:  Anastasia Khvorova; Jonathan K Watts
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

3.  Synthesis and properties of DNA oligonucleotides with a zwitterionic backbone structure.

Authors:  Boris Schmidtgall; Anatol P Spork; Falk Wachowius; Claudia Höbartner; Christian Ducho
Journal:  Chem Commun (Camb)       Date:  2014-11-18       Impact factor: 6.222

4.  Synthesis, biophysical properties, and nuclease resistance properties of mixed backbone oligodeoxynucleotides containing cationic internucleoside guanidinium linkages: deoxynucleic guanidine/DNA chimeras.

Authors:  D A Barawkar; T C Bruice
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Synthesis of c-di-GMP analogs with thiourea, urea, carbodiimide, and guanidinium linkages.

Authors:  Barbara L Gaffney; Roger A Jones
Journal:  Org Lett       Date:  2013-12-06       Impact factor: 6.005

6.  Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.

Authors:  S Futaki; T Suzuki; W Ohashi; T Yagami; S Tanaka; K Ueda; Y Sugiura
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

7.  Tandem regioselective synthesis of tetrazoles and related heterocycles using iodine.

Authors:  Ramesh Yella; Nilufa Khatun; Saroj Kumar Rout; Bhisma K Patel
Journal:  Org Biomol Chem       Date:  2011-03-23       Impact factor: 3.876

8.  Design and synthesis of deoxynucleic guanidine: a polycation analogue of DNA.

Authors:  R O Dempcy; O Almarsson; T C Bruice
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 9.  Oligonucleotide Therapies: The Past and the Present.

Authors:  Karin E Lundin; Olof Gissberg; C I Edvard Smith
Journal:  Hum Gene Ther       Date:  2015-08-03       Impact factor: 5.695

Review 10.  Oligonucleotide analogues with cationic backbone linkages.

Authors:  Melissa Meng; Christian Ducho
Journal:  Beilstein J Org Chem       Date:  2018-06-04       Impact factor: 2.883

View more
  2 in total

1.  Automated Synthesis and Purification of Guanidine-Backbone Oligonucleotides.

Authors:  Kacper Skakuj; Katherine E Bujold; Chad A Mirkin
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2020-06

2.  Synthesis of siRNAs incorporated with cationic peptides R8G7 and R8A7 and the effect of the modifications on siRNA properties.

Authors:  Miho Matsubara; Kenji Honda; Koki Ozaki; Ryohei Kajino; Yuri Kakisawa; Yusuke Maeda; Yoshihito Ueno
Journal:  RSC Adv       Date:  2020-09-21       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.